Topical emulgel formulation containing inclusion complex of calcipotriol with cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 78, Issue 1-4, 2014, Pages 249-255

  Badilli, Ulya ^a   Amasya, Gülin ^a   Şen, Tangül ^a   Tarimci, Nilüfer ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Calcipotriol; Captisol ; Emulgel; Inclusion complex

Indexed keywords

EID: 84893766632     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-013-0293-2     Document Type: Article

References (22)

1. Lebwohl, M.: A clinician's paradigm in the treatment of psoriasis. J. Am. Acad. Dermatol. 53, S59-S69 (2005)
2. Nelson, A.A.; Pearce, D.J.; Fleischer, A.B.; Balkrishnan, R.; Feldman, S.R.: New treatments for psoriasis: which biologic is best? J. Dermatol. Treat. 17, 96-107 (2006)
3. Laws, P.M.; Young, H.S.: Topical treatment of psoriasis. Expert Opin. Pharmacother. 11(12), 1999-2009 (2010)
4. Basavaraj, K.H.; Navya, M.A.; Rashmi, R.: Stress and quality of life in psoriasis: an update. Int. J. Dermatol. 50, 783-792 (2011)
5. Mendonça, C.O.; Burden, A.D.: Current concepts in psoriasis and its treatment. Pharmacol. Ther. 99, 133-147 (2003)
6. Tiberio, R.; Bozzo, C.; Pertusi, G.; Graziola, F.; Gattoni, M.; Griffanti, P.; Boggio, P.; Colombo, E.; Leigheb, G.: Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin. Exp. Dermatol. 34, e972-e974 (2009)
7. Reich, K.; Bewley, A.: What is new in topical therapy for psoriasis? J. Eur. Acad. Dermatol. Venereol. 25(Suppl 4), 15-20 (2011)
8. Knudsen, N.Ø.; Jorgensen, L.; Hansen, J.; Vermehren, C.; Frokjaer, S.; Foged, C.: Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity. Int. J. Pharm. 416(2), 478-485 (2011)
9. Knudsen, N.Ø.; Rønholt, S.; Salte, R.D.; Jorgensen, L.; Thormann, T.; Basse, L.H.; Hansen, J.; Frokjaer, S.; Foged, C.: Calcipotriol delivery into the skin with PEGylated liposomes. Eur. J. Pharm. Biopharm. 81, 532-539 (2012)
10. 1 receptor. Int. J. Pharm. 428, 171-177 (2012)
11. Lin, Y.-K.; Huang, Z.-R.; Zhuo, R.-Z.; Fang, J.-Y.: Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomed. 5, 117-128 (2010)
12. Loftsson, T.; Jarho, P.; Másson, M.; Järvinen, T.: Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2(2), 335-351 (2005)
13. Laza-Knoerr, A.L.; Gref, R.; Couvreur, P.: Cyclodextrins for drug delivery. J. Drug Target. 18(9), 645-656 (2010)
14. Loftsson, T.; Brewster, M.E.: Pharmaceutical applications of cyclodextrins: basic science and product development. J. Pharm. Pharmacol. 62, 1607-1621 (2010)
15. Loftsson, T.; Petersen, D.S.: Cyclodextrin solubilization of water-insoluble drugs: calcipotriol and EB-1089. Pharmazie 52(10), 783-785 (1997)
16. Demirel, M.; Yurtdaş, G.; Genç, L.: Inclusion complexes of ketoconazole with beta-cyclodextrin: physicochemical characterization and in vitro dissolution behaviour of its vaginal suppositories. J. Incl. Phenom. Macrocycl. Chem. 70, 437-445 (2011)
17. Bandarkar, F.S.; Vavia, P.R.: An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin. Drug Dev. Ind. Pharm. 37(11), 1318-1328 (2011)
18. Kakran, M.; Sahoo, N.G.; Li, L.; Judeh, Z.: Dissolution enhancement of artemisinin with β-cyclodextrin. Chem. Pharm. Bull. 59(5), 646-652 (2011)
19. Yan, Z.; Xu, W.; Sun, J.; Liu, X.; Zhao, Y.; Sun, Y.; Zhang, T.; He, Z.: Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-β-cyclodextrin. Drug Dev. Ind. Pharm. 34, 632-641 (2008)
20. Wang, L.; Zeng, F.; Zong, L.: Development of orally disintegrating tablets of perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex. Pharm. Dev. Technol. (2012). doi: 10.3109/10837450.2012.700932
21. Dandawate, P.R.; Vyas, A.; Ahmad, A.; Banerjee, S.; Deshpande, J.; Swamy, K.V.; Jamadar, A.; Dumhe-Klaire, A.C.; Padhye, S.; Sarkar, F.H.: Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharm. Res. 29, 1775-1786 (2012)
22. Kutner, A.; Chodynski, M.; Leszczynska, K.; Szelejewski, W.; FItak, H.: Process for the preparation of calcipotriol. Patent number: US 20100222614 (2010)